Telemedicine RTI Visits Shorter When Antibiotic Prescribed

Share this content:
Telemedicine RTI Visits Shorter When Antibiotic Prescribed
Telemedicine RTI Visits Shorter When Antibiotic Prescribed

TUESDAY, Oct. 2, 2018 (HealthDay News) -- In a direct-to-consumer (DTC) telemedicine setting, respiratory tract infection (RTI) encounters in which antibiotics are prescribed are shorter than other encounters, according to a research letter published online Oct. 2 in the Annals of Internal Medicine.

Kathryn A. Martinez, Ph.D., M.P.H., from the Cleveland Clinic, and colleagues examined the correlation between prescription outcome and length of encounters for RTIs in a DTC telemedicine platform. For each encounter, the prescription outcome was categorized as none, antibiotic, or non-antibiotic. Data were included for 13,438 encounters; 49, 14, 12, and 25 percent of the encounters were for sinusitis, pharyngitis, bronchitis, and other RTIs, respectively.

The researchers found that physicians prescribed antibiotics, non-antibiotics, and nothing in 67, 13, and 20 percent of encounters, respectively. There was variation in the rates for prescribing antibiotics, from 15 percent for other RTIs to 91 percent for sinusitis. The mean unadjusted encounter length was 6.6, 8, and 7.5 minutes when antibiotics, non-antibiotics, and nothing were prescribed, respectively. In adjusted analyses, encounters that resulted in nothing being prescribed were 0.33 minutes longer than those resulting in antibiotic prescriptions, while those resulting in a prescription of non-antibiotics were 1.12 minutes longer.

"Because telemedicine encounters are short and physicians are often reimbursed by encounter volume, antibiotic stewardship efforts that lengthen visits even slightly may be challenging to implement," the authors write.

Abstract/Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

Quick New Ebola Test Approved by FDA

Quick New Ebola Test Approved by FDA

Administration authorizes emergency use of first Ebola fingerstick test with portable reader

CDC: Gun Deaths on the Rise in the United States

CDC: Gun Deaths on the Rise in the ...

U.S. has world's highest rate of gun ownership by civilians among industrialized countries

FDA to Ban Most Flavored Electronic Cigarettes

FDA to Ban Most Flavored Electronic Cigarettes

Details of the ban expected to be announced next week

is free, fast, and customized just for you!




Already a member?

Sign In Now »